Pathology, Hematology & Diagnostic Sciences CTU
Professor & Global Director of Pathology and Laboratory Medicine
- Name: Dr. Arsalan Ahmed
A US board-certified pathologist and internationally recognized expert in hematopathology, Dr. Arsalan has led diagnostic innovations across multiple institutions. He brings over 20 years of academic and laboratory excellence, with deep involvement in translational oncology research. His integration of digital pathology, AI-based diagnostics, and advanced lab informatics positions Ziauddin CTU at the forefront of modern cancer trial infrastructure and centralized pathology services.
Consultant Pathologist
- Name: Dr. Muhammad Asad Diwan
Dr. Asad Diwan offers critical support in histopathology, immunohistochemistry, and diagnostic workflows for clinical trials. With particular focus on cancer pathology and biomarker-driven studies, he ensures high-quality specimen evaluation, trial data integrity, and protocol-compliant sample processing—essential for tissue-based investigations.
Consultant Pathologist
- Name: Dr. Sabiha Navaid Khan
Dr. Sabiha brings extensive experience in general pathology and surgical diagnostics, contributing to the backbone of trial-linked lab assessments. Her role strengthens multidisciplinary research by enabling timely and standardized reporting for studies in oncology, infectious diseases, and systemic disorders.
Consultant Chemical Pathologist / Head of Laboratory
- Name: Dr. Erum Salim
As head of the clinical chemistry and diagnostics division, Dr. Erum ensures standardized laboratory operations, high-throughput testing, and stringent quality assurance. Her leadership is pivotal in maintaining GLP/GCLP-aligned infrastructure—supporting biomarker analysis, pharmacokinetics, and lab-based endpoints in clinical trials.
Consultant Hematologist
- Name: Dr. Sehrish Khurshid
Dr. Sehrish specializes in hematologic malignancies and rare blood disorders including lymphomas, leukemias, and coagulopathies. With advanced training in flow cytometry and bone marrow diagnostics, she is a central figure in both interventional and diagnostic hematology studies, ensuring accurate eligibility screening and outcome measurement.
